In the News April 23, 2020

Politico | How a Lack of FDA Inspections Will Likely Lead to Drug Rejections

Cathy Burgess comments on the U.S. Food and Drug Administration’s approach to approving drug applications amid COVID-19.
Media Contact
Nicholas Clarke
Senior Communications Manager
Phone: 212.210.1222

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.